April 12, 2018

Global Blood aims for sickle cell dominance

Global Blood punching above its weight in sickle cell as 2022 sales forecasts for voxelotor hit $529m in 2022.

November 08, 2017

Selecta feels the pain of gout

October 12, 2017

T3MPO change for Ardelyx

July 21, 2017

Data put a dent in Ironwood’s expansion plans

May 15, 2017

Ardelyx runs into problems with tenapanor

January 20, 2017

After first approval Synergy tackles differentiation

October 03, 2016

Allergan shows it has stomach for more GI dealmaking

June 17, 2016

Upcoming events – Phase III data for plecanatide and Zoptrex

April 27, 2016

Ironwood’s bargain might be a poisoned chalice